[HTML][HTML] The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells

I Corre, F Paris, J Huot - Oncotarget, 2017 - ncbi.nlm.nih.gov
By gating the traffic of molecules and cells across the vessel wall, endothelial cells play a
central role in regulating cardiovascular functions and systemic homeostasis and in …

VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives

M Malekan, NK Haass, GR Rokni, N Gholizadeh… - Life sciences, 2024 - Elsevier
Melanoma is responsible for most skin cancer-associated deaths globally. The progression
of melanoma is influenced by a number of pathogenic processes. Understanding the …

Vascular endothelial growth factor‐C in activating vascular endothelial growth factor receptor‐3 and chemokine receptor‐4 in melanoma adhesion

YN Hlophe, AM Joubert - Journal of Cellular and Molecular …, 2022 - Wiley Online Library
Vascular endothelial growth factor‐C (VEGF‐C) binds to receptor vascular endothelial
growth factor receptor‐3 (VEGFR‐3) expressed on lymphatic endothelial and melanoma …

Non-animal models in dermatological research

E Dellambra, T Odorisio, D D'Arcangelo… - ALTEX-Alternatives to …, 2019 - altex.org
Despite being widely used for basic and preclinical studies in dermatology, available animal
models only partly recapitulate human skin features, often leading to disappointing outputs …

Lymphatic changes in cancer and drug delivery to the lymphatics in solid tumors

B Cote, D Rao, RG Alany, GS Kwon… - Advanced Drug Delivery …, 2019 - Elsevier
Although many solid tumors use the lymphatic system to metastasize, there are few
treatment options that directly target cancer present in the lymphatic system, and those that …

Lipid droplet‐mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib

B Englinger, A Laemmerer, P Moser… - … journal of cancer, 2020 - Wiley Online Library
Ponatinib is a small molecule multi‐tyrosine kinase inhibitor clinically approved for
anticancer therapy. Molecular mechanisms by which cancer cells develop resistance …

Flavonoids effects on hepatocellular carcinoma in murine models: A systematic review

ER García, EA Gutierrez, FCSA Melo… - Evidence‐Based …, 2018 - Wiley Online Library
The hepatocellular carcinoma (HCC) is the second most common cause of cancer deaths
worldwide. It occurs primarily as manifestation of other pathological processes, such as viral …

P38 mediates tumor suppression through reduced autophagy and actin cytoskeleton changes in NRAS-mutant melanoma

I Banik, A Ghosh, E Beebe, B Burja, M Frank Bertoncelj… - Cancers, 2023 - mdpi.com
Simple Summary Mutations in NRAS are the second most common driver mutation in
melanoma and lack therapy options. We discovered that p38 plays the role of a tumor …

[HTML][HTML] Inhibition of p38/MK2 signaling prevents vascular invasion of melanoma

J Wenzina, S Holzner, E Puujalka, PF Cheng… - Journal of Investigative …, 2020 - Elsevier
Melanoma cells can switch between distinct gene expression profiles, resulting in
proliferative or invasive phenotypes. Signaling pathways involved in this switch were …

[HTML][HTML] Steroid receptor RNA activator, a long noncoding RNA, activates p38, facilitates epithelial-mesenchymal transformation, and mediates experimental …

CH Hong, JC Ho, CH Lee - Journal of Investigative Dermatology, 2020 - Elsevier
Melanoma metastasis signals dismal prognosis even with current checkpoint inhibitors.
Long noncoding RNAs (lncRNAs) regulate dynamic metastasis in several cancers, including …